Cure My Disease

Don't miss your cure!

 Log in / Sign up

Cheaper chemo on the horizon? new trial tests generic paclitaxel for breast cancer

NCT ID NCT06765590

Recruiting now Disease control Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a generic version of the chemotherapy drug paclitaxel albumin-bound works the same as the brand-name version in people with breast cancer. The trial involves 24 participants who will receive both versions at different times to compare how the drug behaves in their bodies. The goal is to see if the generic can be a safe and effective alternative, potentially making treatment more affordable.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
paclitaxel albumin-bound (a chemotherapy drug)
What this could lead to
If successful, this could show that a generic version of this chemotherapy is as effective as the brand-name drug, potentially lowering treatment costs for breast cancer patients.
What could go wrong
This is a small, early-stage bioequivalence study, not designed to prove the drug works better or cures cancer. It only checks if the generic matches the reference drug in the body, not long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

  • The First Affiliated hospital of Hennan University of Science & Technology

    RECRUITING

    Luoyang, Henan, 471003, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.